Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?

被引:58
作者
Moon, Suerie [1 ,2 ]
Bermudez, Jorge [3 ]
't Hoen, Ellen [4 ]
机构
[1] Harvard Global Hlth Inst, Cambridge, MA USA
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[3] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil
[4] Univ Amsterdam, Res Sch Social Sci, IS Acad HIV AIDS, NL-1012 WX Amsterdam, Netherlands
关键词
FRAMEWORK; PATENTS; PRIZES;
D O I
10.1371/journal.pmed.1001218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:5
相关论文
共 65 条
[41]  
Medicines for Malaria Venture, 2012, COST EFF IS MMV
[42]  
Moon S, 2011, PHARM PRODUCTION REL
[43]   A breakthrough in R&D for neglected diseases:: New ways to get the drugs we need [J].
Moran, M .
PLOS MEDICINE, 2005, 2 (09) :828-832
[44]  
Moran M, 2011, G FINDER REPORT 2011
[45]   Can Open-Source Drug R&D Repower Pharmaceutical Innovation? [J].
Munos, B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (05) :534-536
[46]   WHO Framework Convention on Tobacco Control: a key milestone [J].
Nikogosian, Haik .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2010, 88 (02) :83-83
[47]  
Sell SusanK., 2003, PRIVATE POWER PUBLIC
[48]  
Serafino D, 2007, 6 KEI
[49]  
Strom Stephanie, 2003, NY TIMES
[50]   Driving a decade of change: HIV/AIDS, patents and access to medicines for all [J].
't Hoen, Ellen ;
Berger, Jonathan ;
Calmy, Alexandra ;
Moon, Suerie .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2011, 14